ETFs positioned on Marksans Pharma Limited

Name Weight AuM 1st Jan change Investor Rating
0.00% 113 M€ +7.83% -
Logo Marksans Pharma Limited
Marksans Pharma Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. The Company produces goods across various therapeutic areas, such as pain management, cough and cold, cardiovascular and central nervous system, anti-diabetic, gastrointestinal, hormonal treatment, and anti-allergic, among others. The Company operates four manufacturing facilities across India, the United Kingdom and the United States. The Company manufactures oral solid tablets, soft gelatin capsules and hard capsules in Goa. It also manufactures non-sterile liquids, ointments and powder products and caters to the United Kingdom, West Africa and the Middle East, which is located in the United Kingdom. The Company has spread its facility to over 7000 square meters and manufactures tablets and capsules in the United States.
Employees
852
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
187.22INR
Average target price
215.00INR
Spread / Average Target
+14.84%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MARKSANS Stock
  4. ETFs Marksans Pharma Limited